|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 41065 |
FusionGeneSummary for USP32_SPANXN4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: USP32_SPANXN4 | Fusion gene ID: 41065 | Hgene | Tgene | Gene symbol | USP32 | SPANXN4 | Gene ID | 84669 | 441525 |
| Gene name | ubiquitin specific peptidase 32 | SPANX family member N4 | |
| Synonyms | NY-REN-60|USP10 | CT11.9 | |
| Cytomap | 17q23.1-q23.2 | Xq27.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | ubiquitin carboxyl-terminal hydrolase 32deubiquitinating enzyme 32renal carcinoma antigen NY-REN-60ubiquitin specific protease 32ubiquitin thioesterase 32ubiquitin thiolesterase 32ubiquitin-specific-processing protease 32 | sperm protein associated with the nucleus on the X chromosome N4cancer/testis antigen family 11, member 9nuclear-associated protein SPAN-Xn4 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q8NFA0 | Q5MJ08 | |
| Ensembl transtripts involved in fusion gene | ENST00000300896, ENST00000592339, ENST00000393003, ENST00000586881, | ENST00000446864, ENST00000370504, | |
| Fusion gene scores | * DoF score | 28 X 15 X 9=3780 | 1 X 1 X 1=1 |
| # samples | 27 | 1 | |
| ** MAII score | log2(27/3780*10)=-3.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: USP32 [Title/Abstract] AND SPANXN4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LGG | TCGA-S9-A6WG-01A | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000300896 | ENST00000446864 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| In-frame | ENST00000300896 | ENST00000370504 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| intron-3CDS | ENST00000592339 | ENST00000446864 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| intron-3CDS | ENST00000592339 | ENST00000370504 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| Frame-shift | ENST00000393003 | ENST00000446864 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| In-frame | ENST00000393003 | ENST00000370504 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| intron-3CDS | ENST00000586881 | ENST00000446864 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
| intron-3CDS | ENST00000586881 | ENST00000370504 | USP32 | chr17 | 58422842 | - | SPANXN4 | chrX | 142121811 | + |
Top |
FusionProtFeatures for USP32_SPANXN4 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| USP32 | SPANXN4 |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for USP32_SPANXN4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_USP32_ENST00000300896_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_193aa MGAKESRIGFLSYEEALRRVTDVELKRLKDAFKRTCGLSYYMGQHCFIREVLGDGVPPKVAEKKNLHRASAPEQSLKETEKAKYPTLVFY CRKNKKRNSNQLENNQPTESSTDPIKEKGDLDISAGSPQDGEEEKDLVFLGARACLEEHIRRSVLYVGDSDTLSKMKTSESPPSGHIPQS >In-frame_USP32_ENST00000393003_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_193aa MGAKESRIGFLSYEEALRRVTDVELKRLKDAFKRTCGLSYYMGQHCFIREVLGDGVPPKVAEKKNLHRASAPEQSLKETEKAKYPTLVFY CRKNKKRNSNQLENNQPTESSTDPIKEKGDLDISAGSPQDGEEEKDLVFLGARACLEEHIRRSVLYVGDSDTLSKMKTSESPPSGHIPQS |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_USP32_ENST00000300896_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_579nt ATGGGTGCCAAGGAGTCACGGATCGGATTCCTCAGCTACGAGGAGGCGCTGAGGAGAGTTACAGATGTAGAGCTAAAACGACTGAAGGAT GCTTTCAAGAGGACCTGTGGACTCTCATATTACATGGGCCAGCACTGCTTCATCCGGGAAGTGCTTGGGGATGGAGTGCCTCCAAAGGTT GCTGAGAAGAAGAATCTGCACAGAGCCTCAGCCCCTGAACAGAGTTTGAAAGAGACAGAAAAAGCAAAATATCCAACATTAGTGTTTTAC TGCAGGAAGAATAAGAAAAGAAATTCAAATCAACTGGAGAATAACCAGCCTACAGAGAGCTCCACTGATCCAATCAAAGAGAAAGGAGAC CTAGACATATCTGCAGGATCTCCACAGGATGGAGAGGAAGAAAAGGATTTGGTGTTCCTTGGAGCACGTGCATGTTTAGAAGAGCACATA AGAAGATCTGTATTGTATGTAGGTGACAGTGACACTCTTTCCAAAATGAAGACATCAGAATCACCACCTTCAGGCCACATACCTCAGAGT >In-frame_USP32_ENST00000393003_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_579nt ATGGGTGCCAAGGAGTCACGGATCGGATTCCTCAGCTACGAGGAGGCGCTGAGGAGAGTTACAGATGTAGAGCTAAAACGACTGAAGGAT GCTTTCAAGAGGACCTGTGGACTCTCATATTACATGGGCCAGCACTGCTTCATCCGGGAAGTGCTTGGGGATGGAGTGCCTCCAAAGGTT GCTGAGAAGAAGAATCTGCACAGAGCCTCAGCCCCTGAACAGAGTTTGAAAGAGACAGAAAAAGCAAAATATCCAACATTAGTGTTTTAC TGCAGGAAGAATAAGAAAAGAAATTCAAATCAACTGGAGAATAACCAGCCTACAGAGAGCTCCACTGATCCAATCAAAGAGAAAGGAGAC CTAGACATATCTGCAGGATCTCCACAGGATGGAGAGGAAGAAAAGGATTTGGTGTTCCTTGGAGCACGTGCATGTTTAGAAGAGCACATA AGAAGATCTGTATTGTATGTAGGTGACAGTGACACTCTTTCCAAAATGAAGACATCAGAATCACCACCTTCAGGCCACATACCTCAGAGT |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_USP32_ENST00000300896_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_780nt ACGTGATCCGGCATGGAGGCGGTGGCGGCGACCGGGAGGAGCCGCCGGGGCAGAAGCCGCACTTGTTAGTGTGGGGGGAGGTGGGGGCGG GGGACGCCGACACCGTCACCGTCACCCAGGGACGCCGAGGAGAAGGCGGGAGGGGGGTGGGGGCGAGATCAGGCTCCGACCCCCCGCCGA GGGGATGAGGGGAGCATGGGTGCCAAGGAGTCACGGATCGGATTCCTCAGCTACGAGGAGGCGCTGAGGAGAGTTACAGATGTAGAGCTA AAACGACTGAAGGATGCTTTCAAGAGGACCTGTGGACTCTCATATTACATGGGCCAGCACTGCTTCATCCGGGAAGTGCTTGGGGATGGA GTGCCTCCAAAGGTTGCTGAGAAGAAGAATCTGCACAGAGCCTCAGCCCCTGAACAGAGTTTGAAAGAGACAGAAAAAGCAAAATATCCA ACATTAGTGTTTTACTGCAGGAAGAATAAGAAAAGAAATTCAAATCAACTGGAGAATAACCAGCCTACAGAGAGCTCCACTGATCCAATC AAAGAGAAAGGAGACCTAGACATATCTGCAGGATCTCCACAGGATGGAGAGGAAGAAAAGGATTTGGTGTTCCTTGGAGCACGTGCATGT TTAGAAGAGCACATAAGAAGATCTGTATTGTATGTAGGTGACAGTGACACTCTTTCCAAAATGAAGACATCAGAATCACCACCTTCAGGC >In-frame_USP32_ENST00000393003_chr17_58422842_-_SPANXN4_ENST00000370504_chrX_142121811_+_621nt CAGGCTCCGACCCCCCGCCGAGGGGATGAGGGGAGCATGGGTGCCAAGGAGTCACGGATCGGATTCCTCAGCTACGAGGAGGCGCTGAGG AGAGTTACAGATGTAGAGCTAAAACGACTGAAGGATGCTTTCAAGAGGACCTGTGGACTCTCATATTACATGGGCCAGCACTGCTTCATC CGGGAAGTGCTTGGGGATGGAGTGCCTCCAAAGGTTGCTGAGAAGAAGAATCTGCACAGAGCCTCAGCCCCTGAACAGAGTTTGAAAGAG ACAGAAAAAGCAAAATATCCAACATTAGTGTTTTACTGCAGGAAGAATAAGAAAAGAAATTCAAATCAACTGGAGAATAACCAGCCTACA GAGAGCTCCACTGATCCAATCAAAGAGAAAGGAGACCTAGACATATCTGCAGGATCTCCACAGGATGGAGAGGAAGAAAAGGATTTGGTG TTCCTTGGAGCACGTGCATGTTTAGAAGAGCACATAAGAAGATCTGTATTGTATGTAGGTGACAGTGACACTCTTTCCAAAATGAAGACA |
Top |
FusionGenePPI for USP32_SPANXN4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| USP32 | CDK1, FARSA, KRT8, KRT18, KRT19, ABCD3, YWHAB, TUBA1A, SMC1A, USP6, TRIP13, ERP44, UBXN1, MRPL39, VPS35, LRRC47, USP32P2, USP4, CUL3, CAND1, RBCK1, TRIM46, RNF144A, TRIM74, ZDHHC17, RAP1B, SORT1, SYNCRIP, BAG6, FDFT1, RAB6B, TPCN2, MANSC1, ENTPD7, ALDH3B1, CD83, NME4, HSPA12A, UBC, MTNR1A, TRIM25 | SPANXN4 | SRPK1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for USP32_SPANXN4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for USP32_SPANXN4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|